Connect With Us:
- Prova Education Series
- The GI Health Initiative
- From Guideline to Practice: Managing Challenging Cases in Primary Care
- Acute Coronary Syndrome: Bridging the Gaps in Care
- Getting the Red Out: Conjunctivitis and Ocular-nasal Allergies
- Project Oncology
- Clinician's Commentary
- Diabetes: Optimal Glycemic Control and Preventing Complications
- Assessing and Managing Chronic Pain in Primary Care: Applying Evidence to Clinicial Practice
- Best Practices in the Ongoing Management of Patients with Hemophilia
- Prevention of Pneumococcal Disease in Children: Optimizing Vaccine Strategies
- Preterm and Low Birth Weight Infant Nutrition
- Genetic Profiling in Early-Stage Breast Cancer and Beyond
- Medical Resources and References
Primary care is responsible for managing patients with hyperlipidemia or mixed dyslipidemia. Many of these patients present with concomitant medical problems, including diabetes, hypertension, and coronary artery disease, and erectile dysfunction. Statins have been consistently shown to be highly effective in treating dyslipidemias, and as a class are generally well tolerated.
Achieving Lipid Goals in the Complicated Patient: Update 2012
Join us for this online CME activity as we take an in-depth look at real-life statin efficacy and safety, including critical perspectives on polypharmacy and pharmacogenetics.
Hyperlipidemia Patient Case Studies
Join us for this online, case-based CME activity as we make diagnostic and treatment decisions for two complicated patients with dyslipidemia.
Update on Statin Therapy in Lipid Management and Prevention of Cardiovascular Disease
Join us for this online CME activity as we take an in-depth look at statin efficacy and safety, including critical perspectives on polypharmacy and pharmacogenetics.
The Omnia-Prova Education Collaborative, Inc. (TOPEC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Acknowledgement of Commercial Support
These activities are supported by an independent educational grant from Kowa Pharmaceuticals America, Inc. and Lilly USA, LLC.